Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert

NCT04816773 is registered in ClinicalTrials.gov with MicroPort Orthopedics Inc. as lead sponsor.

NCT NCT04816773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04816773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert
Lead sponsor
MicroPort Orthopedics Inc.
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 27, 2022
Completion date
January 31, 2035
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis knee, avascular necrosis, joint diseases, osteoarthritis